A recent study of over 80,000 patients with type 2 diabetes in England found that Black patients were 50% less likely and Asian patients 15% less likely to be prescribed newer medications such as sodium–glucose cotransporter 2 inhibitors and glucagon-like peptide-1 agonists, compared with their White counterparts [38]. Here, GCG is linked to type 2 diabetes mellitus.